Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Nucleic Acid Therapeutics is Scopus-indexed (Q1, CiteScore 11.4), WoS SCIE. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 2159-3337Verify ISSN ↗2159-3345Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics | 28 / 357 | 92nd | Q1 |
| Biochemistry | 45 / 448 | 90th | Q1 |
| Drug Discovery | 19 / 161 | 88th | Q1 |
| Molecular Medicine | 23 / 179 | 87th | Q1 |
| Molecular Biology | 55 / 414 | 86th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2011–present, best quartile Q1, CiteScore 11.4.
Nucleic Acid Therapeutics is Q1 in Genetics (rank 28 of 357), Q1 in Biochemistry (rank 45 of 448) and Q1 in Drug Discovery (rank 19 of 161), by CiteScore 2025. It is ranked in 5 subject areas in all.
Nucleic Acid Therapeutics is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 11.4, which places it in quartile Q1 at the 92nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.950, quartile Q1, with an H-index of 85.
Nucleic Acid Therapeutics is published by SAGE Publications Ltd. Its print ISSN is 2159-3337 and its online ISSN is 2159-3345.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Nucleic Acid Therapeutics has an h-index of 64 and a 2-year mean of 4.88 citations per paper (OpenAlex). Its Scopus CiteScore is 11.4, quartile Q1. On 2-year citations it ranks #54 of 353 Scopus journals in Genetics.
Nucleic Acid Therapeutics published 34 papers in 2025; its busiest recent year was 2020 with 44. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2023–2026), authors are most often from United States (52.3%), Netherlands (10.9%) and France (5.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.